A pilot cross-sectional study to investigate the biomarker potential of phosphorylated neurofilament-H and immune mediators of disability in patients with 5 year relapsing-remitting multiple sclerosis
Introduction: Multiple sclerosis is the most prevalent chronic autoimmune disease of the central nervous system with the first clinical symptoms typically appearing in early adulthood, and affecting over 2 million people worldwide (1). Relapsing-remitting multiple sclerosis (RRMS) is the current criteria-based most prevalent form of the three clinical presentations of multiple sclerosis (MS), relapsing-remitting, converted to secondary progressive, and primary progressive. It is characterized by neurologic worsening attacks or relapses followed by apparent recovery periods of masked progression of the disease...
Main Authors: | , , , , , , , |
---|---|
Format: | Artículo biblioteca |
Language: | eng |
Published: |
Frontiers In
2019
|
Subjects: | ESCLEROSIS MULTIPLE, DISCAPACIDAD, CITOQUINAS, ENFERMOS, ENFERMEDADES AUTOINMUNES, |
Online Access: | https://repositorio.uca.edu.ar/handle/123456789/9158 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|